Provided by Tiger Trade Technology Pte. Ltd.

Pulmatrix

1.55
+0.05503.68%
Post-market: 1.550.00000.00%16:10 EDT
Volume:16.85K
Turnover:26.04K
Market Cap:5.66M
PE:-1.40
High:1.58
Open:1.43
Low:1.43
Close:1.50
52wk High:5.50
52wk Low:1.16
Shares:3.65M
Float Shares:3.63M
Volume Ratio:0.95
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1034
EPS(LYR):-1.4134
ROE:-98.35%
ROA:-54.69%
PB:3.56
PE(LYR):-1.10

Loading ...

Quince Therapeutics Q2 Net Loss Widens on Acquisition Charges

Reuters
·
Aug 14

Pulmatrix Q2 EPS $(0.29) Up From $(0.42) YoY

Benzinga Earnings
·
Aug 13

Pulmatrix Q2 FY26 Net Loss Narrows to $1.04 Million; Operating Loss Narrows to $1.05 Million

Reuters
·
Aug 13

Pulmatrix Q2 EPS USD -0.29

THOMSON REUTERS
·
Aug 13

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger

THOMSON REUTERS
·
Aug 13

Law Firm Launches Shareholder Rights Investigations into Four M&A Deals Involving PULM, SLP, OLN, and HUN

Deep News
·
Jul 11

Pulmatrix posts audited 2025 net loss of $5.16 million

Reuters
·
Jun 17

Pulmatrix Q1 EPS $(0.32) Up From $(0.50) YoY

Benzinga Earnings
·
May 15

Pulmatrix FY26 Q1 net loss narrows to $1.17 million

Reuters
·
May 15

Pulmatrix Q1 EPS USD -0.32

THOMSON REUTERS
·
May 15

Pulmatrix Announces First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 15

Press Release: Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger

Dow Jones
·
Apr 21

Pulmatrix to Merge With Eos SENOLYTIX, Rebrand on Nasdaq

TIPRANKS
·
Mar 28

Pulmatrix agrees to acquire Eos SENOLYTIX; $19 million financing grows to advance PTC-2105 program

Reuters
·
Mar 26

Pulmatrix Inc - Upon Completion of Merger, Combined Company Will Operate as Eos Senolytix, Inc

THOMSON REUTERS
·
Mar 26

Pulmatrix Inc: $19 Mln Financings to Advance Lead Clinical Candidate PTC-2105 for Sarcopenia and Age-Related Disease

THOMSON REUTERS
·
Mar 26

Pulmatrix Inc - Combined Company Expected to Trade on Nasdaq Under Ticker Symbol "Eosx."

THOMSON REUTERS
·
Mar 26

Press Release: Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

Dow Jones
·
Mar 26

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:59 AM

Reuters
·
Mar 26

Gyre Therapeutics to Buy Cullgen, Which Ends Merger With Pulmatrix

Dow Jones
·
Mar 02